Skip to main content
Advertisement

Main menu

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET

User menu

  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Journal of Pharmacology and Experimental Therapeutics
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET
  • My alerts
  • Log in
  • My Cart
Journal of Pharmacology and Experimental Therapeutics

Advanced Search

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Visit jpet on Facebook
  • Follow jpet on Twitter
  • Follow jpet on LinkedIn
Research ArticleCARDIOVASCULAR

Influence of Purinoceptor Antagonism on Diadenosine Pentaphosphate-Induced Hypotension in Anesthetized Rats

Martin Steinmetz, Truc Van Le, Peter Hollah, Gert Gabriëls, Helge Hohage, Karl Heinz Rahn and Eberhard Schlatter
Journal of Pharmacology and Experimental Therapeutics September 2000, 294 (3) 963-968;
Martin Steinmetz
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Truc Van Le
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Peter Hollah
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Gert Gabriëls
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Helge Hohage
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Karl Heinz Rahn
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Eberhard Schlatter
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Data
  • Info & Metrics
  • eLetters
  • PDF
Loading

Abstract

Diadenosine polyphosphates (ApnA; n = 3–6) are potent vasoactive agents in isolated vessels. Information on effects of ApnA in vivo is still limited despite the fact that these compounds are starting to be used in humans. This study was designed to compare the effects of ApnA and their possible metabolites on blood pressure in vivo and to functionally identify purinoceptors involved in their action. All four ApnA and their degradation products induced a sustained drop of mean arterial blood pressure during i.v. infusion, which was fully reversible. The rank order of potency was Ap4A ≥ Ap6A > Ap5A = Ap3A = ATP = ADP > AMP ≥ adenosine, suggesting that the hypotensive effect is predominantly evoked by the original dinucleotides and not by their degradation products. The hypotensive effect of Ap5A was reduced by the P2X and P2Y1 purinoceptor antagonist pyridoxal-phosphate-6-azophenyl-2′,4′-disulfonic acid, the A1 purinoceptor antagonist 8-cyclopentyl-1,3-dipropylxanthine, and the A2 purinoceptor antagonist 3,7-dimethyl-1-propargylxanthine. The hypertensive effect by the prototype P2X receptor agonist αβ-methylene ATP was inhibited by pyridoxal-phosphate-6-azophenyl-2′,4′-disulfonic acid, too. Purinoceptor antagonists reduced the maximal effects of the agonists indicating a noncompetitive inhibition. In summary, the reported vasocontractile effect of ApnA seems to be limited to isolated preparations under resting tone conditions; however, the systemic cardiovascular effects of all four ApnA are hypotensive, also making them candidates for blood pressure reduction in humans. These effects are fast in onset and easily reversible. Activation of different purinoceptors in the vasculature (most probably P2Y1 and A2 receptors) contributes to the Ap5A-induced decrease of mean arterial blood pressure.

Footnotes

  • Send reprint requests to: Prof. Dr. Eberhard Schlatter, Medizinische Poliklinik, Experimentelle Nephrologie, Westfälische Wilhelms-Universität, Domagkstrasse 3a, 48149 Münster, Germany. E-mail: eberhard.schlatter{at}uni-muenster.de

  • ↵1 This study was supported by a grant from the Center for Interdisciplinary Clinical Research (IZKF, project A1) at the Medical Faculty of the University of Münster (BMBF 01 KS 9604/0). A part of this work was presented at the Congress of Nephrology, Erlangen, Germany, 1998, and is published in abstract form (Schlatter et al., 1998).

  • Abbreviations:
    ApnA
    diadenosine polyphosphates
    PPADS
    pyridoxal-phosphate-6-azophenyl-2′,4′-disulfonic acid
    DMPX
    3,7-dimethyl-1-propargylxanthine
    DPCPX
    8-cyclopentyl-1,3-dipropylxanthine
    MABP
    mean arterial blood pressure
    HR
    heart rate
    BPM
    beats per minute
    Ap3A
    P1,P3-diadenosine triphosphate
    Ap4A
    P1,P4-diadenosine tetraphosphate
    Ap5A
    P1,P5-diadenosine pentaphosphate
    Ap6A
    P1,P6-diadenosine hexaphosphate
    • Received December 28, 1999.
    • Accepted May 26, 2000.
  • The American Society for Pharmacology and Experimental Therapeutics
View Full Text

JPET articles become freely available 12 months after publication, and remain freely available for 5 years. 

Non-open access articles that fall outside this five year window are available only to institutional subscribers and current ASPET members, or through the article purchase feature at the bottom of the page. 

 

  • Click here for information on institutional subscriptions.
  • Click here for information on individual ASPET membership.

 

Log in using your username and password

Forgot your user name or password?

Purchase access

You may purchase access to this article. This will require you to create an account if you don't already have one.
PreviousNext
Back to top

In this issue

Journal of Pharmacology and Experimental Therapeutics: 294 (3)
Journal of Pharmacology and Experimental Therapeutics
Vol. 294, Issue 3
1 Sep 2000
  • Table of Contents
  • About the Cover
  • Index by author
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for sharing this Journal of Pharmacology and Experimental Therapeutics article.

NOTE: We request your email address only to inform the recipient that it was you who recommended this article, and that it is not junk mail. We do not retain these email addresses.

Enter multiple addresses on separate lines or separate them with commas.
Influence of Purinoceptor Antagonism on Diadenosine Pentaphosphate-Induced Hypotension in Anesthetized Rats
(Your Name) has forwarded a page to you from Journal of Pharmacology and Experimental Therapeutics
(Your Name) thought you would be interested in this article in Journal of Pharmacology and Experimental Therapeutics.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
Research ArticleCARDIOVASCULAR

Influence of Purinoceptor Antagonism on Diadenosine Pentaphosphate-Induced Hypotension in Anesthetized Rats

Martin Steinmetz, Truc Van Le, Peter Hollah, Gert Gabriëls, Helge Hohage, Karl Heinz Rahn and Eberhard Schlatter
Journal of Pharmacology and Experimental Therapeutics September 1, 2000, 294 (3) 963-968;

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
Research ArticleCARDIOVASCULAR

Influence of Purinoceptor Antagonism on Diadenosine Pentaphosphate-Induced Hypotension in Anesthetized Rats

Martin Steinmetz, Truc Van Le, Peter Hollah, Gert Gabriëls, Helge Hohage, Karl Heinz Rahn and Eberhard Schlatter
Journal of Pharmacology and Experimental Therapeutics September 1, 2000, 294 (3) 963-968;
del.icio.us logo Digg logo Reddit logo Twitter logo CiteULike logo Facebook logo Google logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
    • Abstract
    • Materials and Methods
    • Results
    • Discussion
    • Footnotes
    • References
  • Figures & Data
  • Info & Metrics
  • eLetters
  • PDF

Related Articles

Cited By...

More in this TOC Section

  • Effects of Four COVID-19 Drugs on hERG Channels
  • Anti-apoptotic effect of rosuvastatin via autophagy
  • Improved Assessment of Cardiovascular Safety Data
Show more Cardiovascular

Similar Articles

Advertisement
  • Home
  • Alerts
Facebook   Twitter   LinkedIn   RSS

Navigate

  • Current Issue
  • Fast Forward by date
  • Fast Forward by section
  • Latest Articles
  • Archive
  • Search for Articles
  • Feedback
  • ASPET

More Information

  • About JPET
  • Editorial Board
  • Instructions to Authors
  • Submit a Manuscript
  • Customized Alerts
  • RSS Feeds
  • Subscriptions
  • Permissions
  • Terms & Conditions of Use

ASPET's Other Journals

  • Drug Metabolism and Disposition
  • Molecular Pharmacology
  • Pharmacological Reviews
  • Pharmacology Research & Perspectives
ISSN 1521-0103 (Online)

Copyright © 2021 by the American Society for Pharmacology and Experimental Therapeutics